Wird geladen...
Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer
Gallbladder cancer (GBC) is the leading malignancy of biliary system showing refractory chemoresistance to current first‐line drugs. Growing epidemiological evidences have established that the incidence of GBC exhibits significant gender predominance with females two‐threefold higher than males, sug...
Gespeichert in:
| Veröffentlicht in: | J Cell Mol Med |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6991689/ https://ncbi.nlm.nih.gov/pubmed/31782270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14851 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|